Cardiovascular diseases are among the leading causes of morbidity and mortality. Despite scientific and technical progress in risk prediction, diagnostics, prognostication and therapy of cardiovascular pathologies, new biomarkers and therapeutic targets remain the subject of intense research to reduce the burden of these diseases. High throughput analyses, termed “omics”, are a promising avenue of research. These recently developed technical fields have revolutionized biological and medical research in a very short time. By their interdisciplinary nature, these new methods have already provided a wide vision of cell and tissue pathways and functions. Here, we review how these methods can help to discover new biomarkers and therapeutic targets in cardiovascular diseases.
CITATION STYLE
Rabani, V., & Davani, S. (2018). Translational approaches in cardiovascular diseases by “omics.” Current Issues in Molecular Biology, 28, 1–14. https://doi.org/10.21775/cimb.028.001
Mendeley helps you to discover research relevant for your work.